Drug exposure and patient disposition
| Event . | Group 1; n = 13 . | Group 2; n = 12 . | Group 3; n = 12 . | All patients; n = 37 . |
|---|---|---|---|---|
| Treatment duration, wk | ||||
| Median | 12 | 7 | 7 | 8 |
| Range | 4-36 | 1-67 | 3-36 | 1-67 |
| Discontinuation, n (%) | ||||
| Adverse event | 1 (8) | 4 (33) | 2 (17) | 7 (19) |
| Progressive disease | 10 (77) | 7 (58) | 8 (67) | 25 (68) |
| Other | 1 (8) | 0 (0) | 0 (0) | 1 (3) |
| Withdrew consent | 1 (8) | 1 (8) | 2 (17) | 4 (11) |
| Event . | Group 1; n = 13 . | Group 2; n = 12 . | Group 3; n = 12 . | All patients; n = 37 . |
|---|---|---|---|---|
| Treatment duration, wk | ||||
| Median | 12 | 7 | 7 | 8 |
| Range | 4-36 | 1-67 | 3-36 | 1-67 |
| Discontinuation, n (%) | ||||
| Adverse event | 1 (8) | 4 (33) | 2 (17) | 7 (19) |
| Progressive disease | 10 (77) | 7 (58) | 8 (67) | 25 (68) |
| Other | 1 (8) | 0 (0) | 0 (0) | 1 (3) |
| Withdrew consent | 1 (8) | 1 (8) | 2 (17) | 4 (11) |